A detailed history of Gamma Investing LLC transactions in Regenxbio Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 3,429 shares of RGNX stock, worth $25,751. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,429
Previous 919 273.12%
Holding current value
$25,751
Previous $9.64 Million 174.96%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 02, 2025

BUY
$7.23 - $11.56 $18,147 - $29,015
2,510 Added 273.12%
3,429 $26.5 Million
Q3 2024

Oct 04, 2024

BUY
$10.49 - $14.39 $7,384 - $10,130
704 Added 327.44%
919 $9.64 Million
Q2 2024

Jul 02, 2024

SELL
$11.51 - $21.53 $4,143 - $7,750
-360 Reduced 62.61%
215 $2.52 Million
Q1 2024

Apr 05, 2024

BUY
$12.17 - $24.61 $6,206 - $12,551
510 Added 784.62%
575 $12.1 Million
Q4 2023

Feb 01, 2024

BUY
$12.89 - $20.82 $837 - $1,353
65 New
65 $801,000

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $325M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.